CATEGORIES

Healthcare

LATEST

TRENDING

EDITORS CHOICE

Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

This article was published orginally in Fortune and is authored by Arthur Allen and republished with permission from KHN (@khnews). The drug industry, patient advocates,...

Nonsensical Processes Prevent Patient Access to New and Safe Treatments

Health technological innovations only have value if doctors and patients have access to them. Insurance companies label new products as investigational to justify the denial of care.

Flawed Research, Clever Marketing, and the Failure of a Depression Theory

Research based on cherry-picking statistics and small studies suited the needs of the pharmaceutical industry, but it may have been all wrong.

Product Recall: Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP

Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up